Jonathan Heeney | Chief Scientific Officer
DIOSynVax Limited

Jonathan Heeney has had a distinguished career in academia and is a visionary leader in the vaccine Biotech industry. As Professor at the University of Cambridge he has headed the Lab of Viral Zoonotics for 18 years and made seminal contributions to understanding the immune correlates of immune protection to guide the development of next-generation vaccine designs. As the Chief Scientific Officer of DIOSynVax Limited, he spearheads cutting-edge research team applying AI to revolutionize vaccines. With a proven track record of innovation and expertise in immunology, virology, and vaccine design, Jonathan is at the forefront of developing a new class of "safer, stronger vaccines for today, smarter for tomorrow" to combat complex infectious diseases and improve public health worldwide.

Jonathan's career spans over two and a half decades, during which he has made significant contributions to the field of vaccinology. His groundbreaking research has led to the development of novel vaccine platforms that have the potential to transform the way we prevent and control infectious diseases. Jonathan's commitment to scientific excellence and his ability to translate research findings into tangible solutions make him a sought-after expert in the industry. At DIOSynVax Limited, Jonathan leads a talented team of researchers and collaborators in advancing innovative vaccine candidates through preclinical and clinical development. His strategic vision and collaborative approach have positioned the company as a key player in the global vaccine market, with a focus on addressing unmet medical needs and improving vaccine efficacy and safety.

Jonathan is a respected thought leader and speaker, regularly sharing his insights and expertise at International conferences. His passion for scientific discovery, dedication to public health, and commitment to driving positive change in the vaccine industry make him a valuable asset to the global health community.